Abnormal expression of hepatomas and circulating telomerase and its clinical values

Hepatobiliary and Pancreatic Diseases International

Volumn 4, Issue 4, 2005, Pages 544-549

  Wu, Wei ^a   Yao, Deng Fu ^a   Qiu, Li Wei ^a   Wu, Xin Hua ^a   Yao, Ming ^a   Su, Xiao Qin ^a   Zou, Li ^a  

^a NANTONG UNIVERSITY   (China)

Author keywords

Hepatocellular carcinoma; Peripheral blood; Telomerase; TRAP ELISA

Indexed keywords

ALPHA FETOPROTEIN; MESSENGER RNA; TELOMERASE; TELOMERASE REVERSE TRANSCRIPTASE;

ADULT; ARTICLE; ARTIFICIAL EMBOLISM; CONTROLLED STUDY; DIAGNOSTIC VALUE; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN TISSUE; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; PERIPHERAL BLOOD MONONUCLEAR CELL; PROGNOSIS; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY;

BALLOON OCCLUSION; CARCINOMA, HEPATOCELLULAR; DIAGNOSIS, DIFFERENTIAL; DNA-BINDING PROTEINS; ENZYME-LINKED IMMUNOSORBENT ASSAY; HEPATITIS; HUMANS; LIVER CIRRHOSIS; LIVER NEOPLASMS; REFERENCE VALUES; RNA, MESSENGER; RNA, NEOPLASM; TELOMERASE;

EID: 28444494790     PISSN: 14993872     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Oh BK, Kim YJ, Park C, Park YN. Up-regulation of telomere-binding proteins, TRF1, TRF2, and TIN2 is related to telomere shortening during human multistep hepatocarcinogenesis. Am J Pathol 2005;166:73-80.
2. Shay JW, Wright WE. Ageing and cancer: the telomere and telomerase connection. Novartis Found Symp 2001;235:116-125.
3. Testorelli C. Telomerase and cancer. J Exp Clin Cancer Res 2003;22:165-169.
4. de Lange T. Activation of telomerase in a human tumor. Proc Natl Acad Sci USA 1994;91:2882-2885.
5. Mariani E, Meneghetti A, Formentini I, Neri S, Cattini L, Ravaglia G, et al. Telomere length and telomerase activity: effect of ageing on human NK cells. Mech Ageing Dev 2003; 124:403-408.
6. Mu J, Wei LX. Telomere and telomerase in oncology. Cell Res 2002;12:1-7.
7. Masutomi K, Yu EY, Khurts S, Ben-Porath I, Currier JL, Metz GB, et al. Telomerase maintains telomere structure in normal human cells. Cell 2003;114:241-253.
8. Morin GB. The human telomere transferase enzyme is a ribonucleoprotein that synthesizes TTAGGG repeats. Cell 1989; 59:521-529.
9. Satyanarayana A, Manns MP, Rudolph KL. Telomeres and telomerase: a dual role in hepatocarcinogenesis. Hepatology 2004;40:276-283.
10. Nakajima T, Katagishi T, Moriguchi M, Sekoguchi S, Nishikawa Y, Takashima H, et al. Tumor size-independence of telomerase length indicates an aggressive feature of HCC. Biochem Biophys Res Commun 2004;325:1131-1135.
11. Rhyu MS. Telomeres, telomerase, and immortality. J Natl Cancer Inst 1995;87:884-894.
12. Iizuka N, Mori N, Tamesa T, Tangoku A, Oka M. Telomerase activity and Nm23-H2 protein expression in hepatocellular carcinoma. Anticancer Res 2003;23:43-47.
13. Burger AM, Bibby MC, Double JA. Telomerase activity in normal and malignant mammalian tissues: feasibility of telomerase as a target for cancer chemotherapy. Br J Can 1997;75:516-522.
14. Onishi T, Nouso K, Higashi T, Toshikuni N, Nakatsukasa H, Kobayashi Y, et al. Cellular distribution of telomerase reverse transcriptase in human hepatocellular carcinoma. J Gastroenterol Hepatol 2003;18:1168-1174.
15. Farazi PA, Glickman J, Jiang S, Yu A, Rudolph KL, Depinho RA. Differential impact of telomere dysfunction on initiation and progression of hepatocellular carcinoma. Cancer Res 2003;63:5021-5027.
16. Wu W, Yao DF, Wu XH, Lu JX, Qiu LW. Abnormal expression of hepatic telomerase and kinetic alteration of its activity during development of hepatocellular carcinoma. Bull Chin Can 1999;8:375-377.
17. Yokota T, Suda T, Igarashi M, Kuroiwa T, Waguri T, Kawai H, et al. Telomere length variation and maintenance in hepatocarcinogenesis. Cancer 2003;98:110-118.
18. Oh BK, Jo Chae K, Park C, Kim K, Jung Lee W, Han KH, et al. Telomere shortening and telomerase reactivation in dysplastic nodules of human hepatocarcinogenesis. J Hepatol 2003;39:786-792.
19. Yao DF, Dong ZZ, Yao DB, Wu XH, Wu W, Qiu LW, et al. Abnormal expression of hepatoma-derived γ-glutamyl-transferase subtyping and its early alteration for carcinogensis of hepatocytes. Hepatobiliary Pancreatic Dis Int 2004;3:564-570.
20. Kim NW, Piatyszek MA, Prowse KR, Harley CB, West MD, Ho PL, et al. Specific association of human telomerase activity with immortal cells and cancer. Science 1994;266: 2011-2015.
21. Habn WC, Meyerson M. Telomerase activation, cellular immortalization and cancer. Ann Med 2001;33:123-129.
22. Yang Y, Chen Y, Zhang C, Huang H, Weissman SM. Nucleolar localization of hTERT protein is associated with telomerase function. Exp Cell Res 2002;277:201-209.
23. Li CP, Huang TS, Chao Y, Chang FY, Whang-Peng J, Lee SD. Advantages of assaying telomerase activity in ascites for diagnosis of digestive tract malignancies. World J Gastroenterol 2004;10:2468-2471.
24. Sato R, Maesawa C, Fujisawa K, Wada K, Oikawa K, Takikawa Y, et al. Prevention of critical telomere shortening by oestradiol in human normal hepatic cultured cells and carbon tetrachloride induced rat liver fibrosis. Gut 2004;53: 1001-1009.
25. Lee CM, Hsu CY, Eng HL, Huang WS, Lu SN, Changchien CS, et al. Telomerase activity and telomerase catalytic subunit in hepatocellular carcinoma. Hepatogastroenterology 2004;51:796-800.
26. Chen CJ, Kyo S, Liu YC, Cheng YL, Hsieh CB, Chan DC, et al. Modulation of human telomerase reverse transcriptase in hepatocellular carcinoma. World J Gastroenterol 2004;10:638-642.
27. Liu YC, Chen CJ, Wu HS, Chan DC, Yu JC, Yang AH, et al. Telomerase and c-myc expression in hepatocellular carcinomas. Eur J Surg Oncol 2004;30:384-390.
28. Piao YF, He M, Shi Y, Tang TY. Relationship between microvessel density and telomerase activity in hepatocellular carcinoma. World J Gastroenterol 2004;10:2147-2149.
29. Qin LX, Tang ZY. The prognostic molecular markers in hepatocellular carcinoma. World J Gastroenterol 2002;8:385-392.
30. Klingelhutz AJ. The roles of telomeres and telomerase in cellular immortalization and the development of cancer. Anticancer Res 1999;19:4823-4830.
31. Thorgeirsson SS, Grisham JW. Molecular pathogenesis of human hepatocellular carcinoma. Nat Genet 2002;31:339-346.